Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

Author:

da Silva Wânia CristinaORCID,de Araujo Vânia EloisaORCID,Lima Ellias Magalhães e Abreu,dos Santos Jessica Barreto RibeiroORCID,Silva Michael Ruberson Ribeiro daORCID,Almeida Paulo Henrique Ribeiro FernandesORCID,de Assis Acurcio FranciscoORCID,Godman BrianORCID,Kurdi AmanjORCID,Cherchiglia Mariângela LealORCID,Andrade Eli Iola GurgelORCID

Funder

National Scientific and Technological Development Council

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine,Biotechnology

Reference110 articles.

1. Ellen ’t Hoen L. Access to cancer treatment: a study of medicine pricing issues with recommendations for improving access to cancer medication [Internet]. World Health Organization. 2014 [cited 2018 Jan]. Available from: http://apps.who.int/medicinedocs/en/d/Js21758en/ .

2. WHO | Cancer. 2018 Jan 30 [cited 2018 Jan 31]; Available from: http://www.who.int/cancer/en/ .

3. IARC. GLOBOCAN—Estimated colorectal cancer mortality worldwide in 2012 [Internet]. GLOBOCAN. 2012. Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx?cancer=colorectal .

4. Noonan AM, Bekaii-Saab T. Second-line outcomes in metastatic colorectal cancer—raising the bar for the high jump rather than the doing the limbo. Expert Rev Pharmacoecon Outcomes Res [Internet]. 2014;15(1):133–43. Available from: http://dx.doi.org/10.1586/14737167.2015.972376 .

5. Van Cutsem E, Cervantes A, Nordlinger B, Arnold D, ESMO Guidelines Working Group. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol [Internet]. 2014;25(Suppl 3):iii1–9. Available from: http://dx.doi.org/10.1093/annonc/mdu260 .

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3